Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials

<div>The cumulative rank diagram of the estimated probability among placebo and the 7 compared statins in (a) LDL-C network meta-analysis, (b) HDL-C network meta-analysis, (c) TC network meta-analysis, (d) TG network meta-analysis, (e) ApoA1 network meta-analysis, and (f) ApoB network meta-analysis.</div>

Cardiovascular Therapeutics

fig6

Figure 6

Figure 6: Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials 

Figure 6 | Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials 